A novel lymphoma-associated macrophage interaction signature (LAMIS) provides robust risk prognostication in diffuse large B-cell lymphoma clinical trial cohorts of the DSHNHL

Erstveröffentlichung
2020
Authors
Staiger, Annette M.
Altenbuchinger, Michael
Ziepert, Marita
Kohler, Christian
Horn, Heike
et al.
Wissenschaftlicher Artikel


Published in
Leukemia ; 34 (2020), 2. - S. 543-552. - ISSN 0887-6924. - eISSN 1476-5551
Link to publication
https://dx.doi.org/10.1038/s41375-019-0573-y
Institutions
UKU. Institut für Pathologie
UKU. Institut für Humangenetik
Subject headings
[Free subject headings]: OF-ORIGIN CLASSIFICATION | GENE-EXPRESSION | ELDERLY-PATIENTS | REGULARIZATION PATHS | POOR-PROGNOSIS | HIGH-DENSITY | OPEN-LABEL | RITUXIMAB | PREDICTS | SURVIVAL
[DDC subject group]: DDC 610 / Medicine & health
Metadata
Show full item record